Product Description: Deslanoside (Standard) is the analytical standard of Deslanoside. This product is intended for research and analytical applications. Deslanoside (Desacetyllanatoside C) is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. Deslanoside inhibits the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium and calcium concentrations [1][2][3].
Formula: N/A
References: [1]Hauptman PJ, et al. Digitalis. Circulation. 1999 Mar 9;99(9):1265-70./[2]Wang L, et al. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China. Sci Rep. 2017 Oct 23;7(1):13819./[3]Deslanoside./[4]Klys M, et al. Determination of deslanoside in antemortem and postmortem specimens. Unusual case report. Forensic Sci Int. 1990 Apr;45(3):231-8.
CAS Number: 17598-65-1
Molecular Weight: N/A
Research Area: Cardiovascular Disease
Target: Drug Metabolite;Na+/K+ ATPase
English
Deutsch
